Publications et rapports

Wils P, Leroyer A, Fumery M, Fernandez-Nistal A, Gower-Rousseau C, Pariente B. Fistulizing perianal lesions in a French population with Crohn’s disease. Dig Liver Dis. 2021 May;53(5):661-665. doi: 10.1016/j.dld.2021.01.010. PMID: 33551356.

Koriche D, Gower-Rousseau C, Chater C, Duhamel A, Salleron J, Tavernier N, Colombel JF, Pariente B, Cortot A, Zerbib P. Post-operative recurrence of Crohn’s disease after definitive stoma: an underestimated risk. Int J Colorectal Dis. 2017 Apr;32(4):453-458. doi: 10.1007/s00384-016-2707-2. Epub 2016 Nov 24.

Fumery M, Kohut M, Gower-Rousseau C, Duhamel A, Brazier F, Thelu F, Nagorniewicz F, Lamarche F, Nguyen-Khac E, Sabbagh C, Loreau J, Colombel JF, Savoye G, Chatelain D, Dupas JL; On behalf on the Somme MC group.; EPIMAD group. Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study. Dig Dis Sci. 2017 Jun;62(6):1571-1579. doi: 10.1007/s10620-016-4306-z. Epub 2016 Sep 22.

Peyrin-Biroulet L, Gower-Rousseau C. The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials. J Crohns Colitis. 2016 Dec;10(12):1375-1377.

Cheddani H, Dauchet L, Fumery M, Charpentier C, Marie Bouvier A, Dupas JL, Pariente B, Peyrin-Biroulet L, Savoye G, Gower-Rousseau C. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. Am J Gastroenterol. 2016 Oct;111(10):1428-1436. doi: 10.1038/ajg.2016.304. PubMed PMID: 27481308.

Fumery M, Duricova D, Gower-Rousseau C, Annese V, Peyrin-Biroulet L, Lakatos PL. Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies. Aliment Pharmacol Ther. 2016 Feb;43(3):346-55. doi: 10.1111/apt.13478. Epub 2015 Nov 18. Review.

Annese V, Duricova D, Gower-Rousseau C, Jess T, Langholz E. Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO. J Crohns Colitis 2016 Feb;10(2):216-25. doi: 10.1093/ecco-jcc/jjv190. Epub 2015 Oct 31. Review.

Penninck E, Fumery M, Armengol-Debeir L, Sarter H, Savoye G, Turck D, Pineton de Chambrun G, Vasseur F, Dupas JL, Lerebours E, Colombel JF, Peyrin-Biroulet L, Gower-Rousseau C; EPIMAD Group. Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study. Inflamm Bowel Dis. 2016 Jan;22(1):127-33.

Gower-Rousseau C, Sarter H, Savoye G, Tavernier N, Fumery M, Sandborn WJ, Feagan BG, Duhamel A, Guillon-Dellac N, Colombel JF, Peyrin-Biroulet L; and the International Programme to Develop New Indexes for Crohn’s Disease (IPNIC) group; International Programme to Develop New Indexes for Crohn’s Disease IPNIC group. Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort. Gut. 2015 Dec 8. pii: gutjnl-2015-310151. doi: 10.1136/gutjnl-2015-310151.

Pineton de Chambrun G, Dauchet L, Gower-Rousseau C, Cortot A, Colombel JF, Peyrin-Biroulet L. Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies. Clin Gastroenterol Hepatol. 2015 Aug;13(8):1405-15.

Fumery M, Dauchet L, Vignal C, Gower-Rousseau C. [Epidemiology, risk factors and factors associated with disabling course in inflammatory bowel disease]. Rev Prat. 2014 Nov;64(9):1210-5.

Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL; ECCO-EpiCom. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis. 2014 Nov;8(11):1351-61.

Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV Jr, Nguyen GC, Ananthakrishnan AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ, Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis. 2014 Feb;20(2):398-415.

Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol. 2014 Feb;11(2):88-98.

Zéphir H, Gower-Rousseau C, Salleron J, Simon O, Debouverie M, Le Page E, Bouhnik Y, Lebrun-Frenay C, Papeix C, Vigneron B, Allez M, Prin L, Cosnes J, Vermersch P, Colombel JF; for the CFSEP, GETAID and EPIMAD Groups. Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease. Mult Scler. 2013 Dec 10;20(8):1135-1139.

Genin M, Duhamel D, Preda C, Fumery M, Savoye G, Peyrin-Biroulet L, et al. Space-time clusters of Crohn’s disease in northern France. Journal of Public Health 21 (6), 497-504.

Fumery M, Xiaocang C, Dauchet L, Gower-Rousseau C, Peyrin-Biroulet L, Colombel JF. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis. 2014 Jun;8(6):469-79.

Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013 Oct;38(8):847-53.

Vasseur F, Sendid B, Broly F, Gower-Rousseau C, Sarazin A, Standaert-Vitse A, Colombel JF, Poulain D, Jouault T. The CARD8 p.C10X mutation associates with a low anti-glycans antibody response in patients with Crohn’s disease. BMC Med Genet. 2013 Mar 18;14:35.

Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, Vasseur F, Dupas JL, Cortot A, Dauchet L, Peyrin-Biroulet L, Lerebours E, Colombel JF, Gower-Rousseau C. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014 Mar;63(3):423-32.

Dreux N, Denizot J, Martinez-Medina M, Mellmann A, Billig M, Kisiela D, Chattopadhyay S, Sokurenko E, Neut C, Gower-Rousseau C, Colombel JF, Bonnet R, Darfeuille-Michaud A, Barnich N. Point mutations in FimH adhesin of Crohn’s disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog. 2013 Jan;9(1):e1003141.

Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, Turck D, Cortot A, Peyrin-Biroulet L, Colombel JF. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis. 2013 Feb;45(2):89-94.

De Vroey B, Gower-Rousseau C, Colombel JF. Exploring life before IBD. Gut. 2013 May;62(5):662-3.

Vasseur F, Sendid B, Jouault T, Standaert-Vitse A, Dubuquoy L, Francois N, Gower-Rousseau C, Desreumaux P, Broly F, Vermeire S, Colombel JF, Poulain D. Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn’s disease and anti-saccharomyces cerevisiae antibody levels. Inflamm Bowel Dis. 2012 Mar;18(3):430-8.

Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011 May;140(6):1785-94.

Chouraki V, Savoye G, Dauchet L, Vernier-Massouille G, Dupas JL, Merle V, Laberenne JE, Salomez JL, Lerebours E, Turck D, Cortot A, Gower-Rousseau C, Colombel JF. The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther. 2011 May;33(10):1133-42.

De Vroey B, De Cassan C, Gower-Rousseau C, Colombel JF. Editorial: Antibiotics earlier, IBD later? Am J Gastroenterol. 2010 Dec;105(12):2693-6.

Declercq C, Gower-Rousseau C, Vernier-Massouille G, Salleron J, Baldé M, Poirier G, Lerebours E, Dupas JL, Merle V, Marti R, Duhamel A, Cortot A, Salomez JL, Colombel JF. Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence. Inflamm Bowel Dis. 2010 May;16(5):807-12.

Cortot A, Pineton de Chambrun G, Vernier-Massouille G, Vigneron B, Gower Rousseau C. [Inflammatory bowel disease: genetic or environmental diseases?]. Gastroenterol Clin Biol. 2009 Aug-Sep;33(8-9):681-91.

Standaert-Vitse A, Sendid B, Joossens M, François N, Vandewalle-El Khoury P, Branche J, Van Kruiningen H, Jouault T, Rutgeerts P, Gower-Rousseau C, Libersa C, Neut C, Broly F, Chamaillard M, Vermeire S, Poulain D, Colombel JF. Candida albicans colonization and ASCA in familial Crohn’s disease. Am J Gastroenterol. 2009 Jul;104(7):1745-53.

Colombel JF, Vernier-Massouille G, Cortot A, Gower-Rousseau C, Salomez JL. [Epidemiology and risk factors of inflammatory bowel diseases]. Bull Acad Natl Med. 2007 Jun;191(6):1105-18; discussion 1118-23.

Van Kruiningen HJ, Joossens M, Vermeire S, Joossens S, Debeugny S, Gower-Rousseau C, Cortot A, Colombel JF, Rutgeerts P, Vlietinck R. Familial Crohn’s disease in Belgium: pedigrees, temporal relationships among cases, and family histories. J Clin Gastroenterol. 2007 Jul;41(6):583-90.

Lerebours E, Gower-Rousseau C, Merle V, Brazier F, Debeugny S, Marti R, Salomez JL, Hellot MF, Dupas JL, Colombel JF, Cortot A, Benichou J. Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Am J Gastroenterol. 2007 Jan;102(1):122-31.

Vernier G, Cortot A, Gower-Rousseau C, Salomez JL, Colombel JF. [Epidemiology and risk factors of inflammatory bowel diseases]. Rev Prat. 2005 May 15;55(9):949-61.

Van Kruiningen HJ, Joossens M, Vermeire S, Joossens S, Debeugny S, Gower-Rousseau C, Cortot A, Colombel JF, Rutgeerts P, Vlietinck R. Environmental factors in familial Crohn’s disease in Belgium. Inflamm Bowel Dis. 2005 Apr;11(4):360-5.

Molinié F, Gower-Rousseau C, Yzet T, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL, Colombel JF, Salomez JL, Cortot A. Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988-1999). Gut. 2004 Jun;53(6):843-8.

Hugot JP, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Zouali H, Lesage S, Chamaillard M, Macry J, Thomas G, Victor JM; GETAID. Clustering of Crohn’s disease within affected sibships. Eur J Hum Genet. 2003 Feb;11(2):179-84.

Zouali H, Lesage S, Merlin F, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Christensen S, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Chamaillard M, Thomas G, Hugot JP; EPWG group; EPIMAD group. CARD4/NOD1 is not involved in inflammatory bowel disease. Gut. 2003 Jan;52(1):71-4.

Lesage S, Zouali H, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group; EPIMAD Group; GETAID Group. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002 Apr;70(4):845-57.

Zouali H, Chamaillard M, Lesage S, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Macry J, Selinger-Leneman H, Thomas G, Hugot JP; GETAID. Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. Eur J Hum Genet. 2001 Oct;9(10):731-42.

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001 May 31;411(6837):599-603.

Laharie D, Debeugny S, Peeters M, Van Gossum A, Gower-Rousseau C, Bélaïche J, Fiasse R, Dupas JL, Lerebours E, Piotte S, Cortot A, Vermeire S, Grandbastien B, Colombel JF. Inflammatory bowel disease in spouses and their offspring. Gastroenterology. 2001 Mar;120(4):816-9.

Van Kruiningen HJ, Mayo DR, Vanopdenbosch E, Gower-Rousseau C, Cortot A, Colombel JF. Virus serology in familial Crohn disease. Scand J Gastroenterol. 2000 Apr;35(4):403-7.

Rolland N, Grandbastien B, Merle V, Gower-Rousseau C, Yzet T, Marti R, Lerebours E, Dupas JL, Czernichow P, Salomez JL, Lebrun T, Cortot A. [Cost of early management of chronic inflammatory intestinal disease]. Gastroenterol Clin Biol. 1999 Apr;23(4):483-8.

Touze I, Gower-Rousseau C, Grandbastien B, Paris JC, Quandalle P, Cortot A, Colombel JF. [Diffuse jejuno-ileitis of Crohn’s disease: a separate form of the disease?]. Gastroenterol Clin Biol. 1999 Mar;23(3):307-11.

Grandbastien B, Gower-Rousseau C, Merle V, Dupas JL, Yzet T, Lerebours E, Marti R, Laine I, Cortot A, Salomez JL. [Diagnostic and therapeutic management of patients with chronic inflammatory bowel disease]. Rev Epidemiol Sante Publique. 1999 Mar;47(1):45-53.

Cortot A, Gower-Rousseau C, Marti R, Colombel JF. [Homogeneous groups of patients in Crohn’s disease: reality or imagination?]. Gastroenterol Clin Biol. 1998 Jun-Jul;22(6-7):591-3.

Grandbastien B, Peeters M, Franchimont D, Gower-Rousseau C, Speckel D, Rutgeerts P, Belaïche J, Cortot A, Vlietinck R, Colombel JF. Anticipation in familial Crohn’s disease. Gut. 1998 Feb;42(2):170-4.

Franchimont D, Belaiche J, Louis E, Simon S, GrandBastien B, Gower-Rousseau C, Fontaine F, Delforge M. Familial Crohn’s disease: a study of 18 families. Acta Gastroenterol Belg. 1997 Apr-Jun;60(2):134-7.

Gower-Rousseau C, Grandbastien B, Colombel JF, Cortot A. [Incidences of chronic inflammatory bowel diseases in France: the table is growing richer]. Gastroenterol Clin Biol. 1997;21(6-7):481-2.

Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Bélaïche J, Hostein J, Hugot JP, van Kruiningen H, Cortot A. Clinical characteristics of Crohn’s disease in 72 families. Gastroenterology. 1996 Sep;111(3):604-7.

Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature. 1996 Feb 29;379(6568):821-3.

Gower-Rousseau C, Grandbastien B, Cortot A, Colombel JF. Epidemiology of inflammatory bowel disease: is there a « Belgian-French exception? ». Acta Gastroenterol Belg. 1996 Jan-Mar;59(1):2.

Neut C, Guillemot F, Gower-Rousseau C, Biron N, Cortot A, Colombel JF. [Treatment of diversion colitis with short-chain fatty acids. Bacteriological study]. Gastroenterol Clin Biol. 1995 Nov;19(11):871-5.

Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, Lemahieu M, Lemaire B, Colombel JF, Cortot A. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994 Oct;35(10):1433-8.

Comes MC, Gower-Rousseau C, Colombel JF, Belaïche J, Van Kruiningen HJ, Nuttens MC, Cortot A. Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of Belgium. Gut. 1994 Sep;35(9):1316-8.

Colombel JF, Gower-Rousseau C, Laurent-Puig P. [Inflammatory bowel diseases: genetic hypothesis]. Acta Gastroenterol Belg. 1994 Sep-Dec;57(5-6):285-91.

Hugot JP, Laurent-Puig P, Gower-Rousseau C, Caillat-Zucman S, Beaugerie L, Dupas JL, Van Gossum A, Bonäit-Pellie C, Cortot A, Thomas G. Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. Am J Med Genet. 1994 Aug 15;52(2):207-13.

Colombel JF, Gower-Rousseau C. [Etiology of Crohn disease. Current data]. Presse Med. 1994 Mar 26;23(12):558-60.

Colombel JF, Gower-Rousseau C. [Crohn disease: will epidemiology find the key?]. Rev Med Interne. 1993 Mar;14(3):147-8.

Notteghem B, Salomez JL, Gower-Rousseau C, Marti R, Lemahieu M, Nuttens MC, Dupas JL, Colombel JF, Cortot A. [What is the prognosis in unclassified colitis? Results of a cohort study of 104 patients in the Northern-Pas-de-Calais region]. Gastroenterol Clin Biol. 1993;17(11):811-5.

Gower-Rousseau C, Maunoury V, Colombel JF, Coulom P, Piette F, Cortot A, Paris JC. Hidradenitis suppurativa and Crohn’s disease in two families: a significant association? Am J Gastroenterol. 1992 Jul;87(7):928.

Colombel JF, Reumaux D, Duthilleul P, Noël LH, Gower-Rousseau C, Paris JC, Cortot A. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol. 1992;16(8-9):656-60.

Cortot A, Gower-Rousseau C, Colombel JF. [Epidemiology and genetics of inflammatory bowel diseases]. Rev Prat. 1991 Feb 11;41(5):393-6.

Colombel JF, Dupas JL, Cortot A, Salomez JL, Marti R, Gower-Rousseau C, Capron-Chivrac D, Lerebours E, Czernichow B, Paris JC. [Incidence of inflammatory bowel disease in the Nord-Pas-de-Calais region and the Somme area of France in 1988]. Gastroenterol Clin Biol. 1990;14(8-9):614-8.

Dupont-Lucas C, Leroyer A, Ley D, Spyckerelle C, Bertrand V, Turck D, Savoye G, Maunoury V, Guillon N, Fumery M, Sarter H, Gower-Rousseau C, the Epimad study group. Increased risk of cancer and mortality in a large French population-based paediatric-onset inflammatory bowel disease retrospective cohort. J Crohns Colitis. J Crohns Colitis. 2023 Apr 19;17(4):524-534. doi: 10.1093/ecco-jcc/jjac166.

Bequet E, Sarter H, Fumery M, Vasseur F, Armengol-Debeir L, Pariente B, Ley D, Spyckerelle C, Coevoet H, Laberenne JE, Peyrin-Biroulet L, Savoye G, Turck D, Gower-Rousseau C; EPIMAD Group. Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]. J Crohns Colitis. 2017 May 1;11(5):519-526.

Fumery M, Pariente B, Sarter H, Savoye G, Spyckerelle C, Djeddi D, Mouterde O, Bouguen G, Ley D, Peneau A, Dupas JL, Turck D, Gower-Rousseau C; Epimad Group. Long-term outcome of pediatric-onset Crohn’s disease: A population-based cohort study. Dig Liver Dis. 2019 Apr;51(4):496-502. doi: 10.1016/j.dld.2018.11.033. PMID: 30611597.

Duricova D, Fumery M, Annese V, Lakatos PL, Peyrin-Biroulet L, Gower-Rousseau C. The natural history of Crohn’s disease in children: a review of population-based studies. Eur J Gastroenterol Hepatol. 2017 Feb;29(2):125-134.

Hochart A, Gower-Rousseau C, Sarter H, Fumery M, Ley D, Spyckerelle C, Peyrin-Biroulet L, Laberenne JE, Vasseur F, Savoye G, Turck D; Epimad Group. Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study. Gut. 2016 Aug 3. pii: gutjnl-2016-311970. doi: 10.1136/gutjnl-2016-311970.

Ley D, Duhamel A, Behal H, Vasseur F, Sarter H, Michaud L, Gower-Rousseau C, Turck D. Growth Pattern in Paediatric Crohn Disease Is Related to Inflammatory Status. J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):637-643.

Peneau A, Savoye G, Turck D, Dauchet L, Fumery M, Salleron J, Lerebours E, Ligier K, Vasseur F, Dupas JL, Mouterde O, Spyckerelle C, Djeddi D, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2013 Oct;108(10):1647-53.

Boualit M, Salleron J, Turck D, Fumery M, Savoye G, Dupas JL, Lerebours E, Duhamel A, Merle V, Cortot A, Colombel JF, Peyrin-Biroulet L, Gower-Rousseau C; EPIMAD Group. Long-term outcome after first intestinal resection in pediatric-onset Crohn’s disease: a population-based study. Inflamm Bowel Dis. 2013 Jan;19(1):7-14.

Savoye G, Salleron J, Gower-Rousseau C, Dupas JL, Vernier-Massouille G, Fumery M, Merle V, Lerebours E, Cortot A, Turck D, Salomez JL, Lemann M, Colombel JF, Duhamel A. Clinical predictors at diagnosis of disabling pediatric Crohn’s disease. Inflamm Bowel Dis. 2012 Nov;18(11):2072-8.

Vasseur F, Gower-Rousseau C, Vernier-Massouille G, Dupas JL, Merle V, Merlin B, Lerebours E, Savoye G, Salomez JL, Cortot A, Colombel JF, Turck D. Nutritional status and growth in pediatric Crohn’s disease: a population-based study. Am J Gastroenterol. 2010 Aug;105(8):1893-900.

Gower-Rousseau C, Dauchet L, Vernier-Massouille G, Tilloy E, Brazier F, Merle V, Dupas JL, Savoye G, Baldé M, Marti R, Lerebours E, Cortot A, Salomez JL, Turck D, Colombel JF. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009 Aug;104(8):2080-8.

Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas JL, Mouterde O, Merle V, Salomez JL, Branche J, Marti R, Lerebours E, Cortot A, Gower-Rousseau C, Colombel JF. Natural history of pediatric Crohn’s disease: a population-based cohort study. Gastroenterology. 2008 Oct;135(4):1106-13.

Jantchou P, Turck D, Baldé M, Gower-Rousseau C. Breastfeeding and risk of inflammatory bowel disease: results of a pediatric, population-based, case-control study. Am J Clin Nutr. 2005 Aug;82(2):485-6.

Auvin S, Molinié F, Gower-Rousseau C, Brazier F, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL, Colombel JF, Salomez JL, Cortot A, Turck D. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr. 2005 Jul;41(1):49-55.

Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005 Mar;54(3):357-63.

Dussault C, Gower-Rousseau C, Salleron J, Vernier-Massouille G, Branche J, Colombel JF, Maunoury V. Small bowel capsule endoscopy for management of Crohn’s disease: a retrospective tertiary care centre experience. Dig Liver Dis. 2013 Jul;45(7):558-61.

Guillemot F, Bouche B, Gower-Rousseau C, Chartier M, Wolschies E, Lamblin MD, Harbonnier E, Cortot A. Biofeedback for the treatment of fecal incontinence. Long-term clinical results. Dis Colon Rectum. 1995 Apr;38(4):393-7.

Gower-Rousseau C, Reumaux D, Bellard M, Delecourt L, Ribet M, Colombel JF. Remission of myasthenia gravis after proctocolectomy in a patient with ulcerative colitis. Am J Gastroenterol. 1993 Jul;88(7):1136-8.

Mesnard B, Colombel JF, Cortot A, Chiche A, Gower-Rousseau C, Paris JC. [Methotrexate treatment in Crohn disease]. Gastroenterol Clin Biol. 1992;16(2):190-1.

Fumery M, Dupont C, Ley D, Savoye G, Bertrand V, Guillon N, Wils P, Gower-Rousseau C, Sarter H, Turck D, Leroyer A. Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study. Dig Liver Dis. 2023 May 1:S1590-8658(23)00577-7. doi: 10.1016/j.dld.2023.04.017.

Penninck E, Fumery M, Armengol-Debeir L, Sarter H, Savoye G, Turck D, Pineton de Chambrun G, Vasseur F, Dupas JL, Lerebours E, Colombel JF, Peyrin-Biroulet L, Gower-Rousseau C; EPIMAD Group. Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study. Inflamm Bowel Dis. 2016 Jan;22(1):127-33. doi: 10.1097/MIB.0000000000000576. PMID: 26355466.

Fumery M, Jacob A, Sarter H, Michaud L, Spyckerelle C, Mouterde O, Savoye G, Colombel JF, Peyrin-Biroulet L, Gower-Rousseau C, Turck D; EPIMAD Group. Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2015 Jun;60(6):744-8.

Gower-Rousseau C, Savoye G, Colombel JF, Peyrin-Biroulet L. Are we improving disease outcomes in IBD? A view from the epidemiology side. Gut. 2014 Oct;63(10):1529-30.

Crombé V, Salleron J, Savoye G, Dupas JL, Vernier-Massouille G, Lerebours E, Cortot A, Merle V, Vasseur F, Turck D, Gower-Rousseau C, Lémann M, Colombel JF, Duhamel A. Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study. Inflamm Bowel Dis. 2011 Oct;17(10):2144-52.